Randall M. Stevens

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

Jonathan Edwards, L Szczepański, Jacek Szechiński et al. · New England Journal of Medicine · 2004 · 2.6K citations · Full text

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

Kim Papp, Kristian Reich, Craig L. Leonardi et al. · Journal of the American Academy of Dermatology · 2015 · 649 citations · Full text

Autoimmune Disease, Medicine, Phase Iii +7

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

Arthur Kavanaugh, Philip J. Mease, Juan J. Gómez‐Reino et al. · Annals of the Rheumatic Diseases · 2014 · 435 citations · Full text

Treatment of arthritis with topical capsaicin: a double-blind trial.

Chad Deal, Thomas J. Schnitzer, Ellen A. Lipstein et al. · PubMed · 1991 · 297 citations

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)

Christopher J Edwards, Francisco J. Blanco, Jeffrey Crowley et al. · Annals of the Rheumatic Diseases · 2016 · 275 citations · Full text